Search
Search Results
##search.searchResults.foundPlural##
-
-
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2038PDF: 1036HTML: 15648COVER LETTER: 186 -
PROPHYLAXIS OF MALARIA
2986PDF: 1014HTML: 17788Figures SChwartz: 159 -
CLINICAL AND HEMATOLOGICAL PROFILE OF PATIENTS WITH DENGUE FEVER AT A TERTIARY CARE HOSPITAL – AN OBSERVATIONAL STUDY
4129PDF: 1733HTML: 488Figure 1: Age distribution of Pediatric cases: 210 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
675PDF: 522HTML: 203 -
Thalidomide treatment for thrombocytopenia secondary to hypersplenism in children with β-thalassemia major: a case series Thalidomide treatment for thrombocytopenia
864PDF: 727HTML: 109 -
Guest Editor: Raffaella Origa IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM. IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION
1898PDF: 1213HTML: 233 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1368PDF: 913HTML: 1643Figure 1: 178 -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2561PDF: 823HTML: 14941Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 297 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
2048PDF: 601Suppl. Files: 283HTML: 161 -
CORD BLOOD PLATELET LYSATE: IN VITRO EVALUATION TO SUPPORT THE USE IN REGENERATIVE MEDICINE. Cord and adult blood platelet lysates
1935PDF: 1127HTML: 245 -
VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF
1293PDF: 854HTML: 1029Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 171 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
2902PDF: 1017HTML: 4575 -
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2129PDF: 1409HTML: 696 -
EXERCISE STRESS ECHOCARDIOGRAPHY WITH TISSUE DOPPLER IMAGING (TDI) DETECTS EARLY SYSTOLIC DYSFUNCTION IN BETA-THALASSEMIA MAJOR PATIENTS WITHOUT CARDIAC IRON OVERLOAD
1299PDF: 799HTML: 7861Manuscript after revision: 240Barbero10328-36310-after revision: 229 -
Anemia in the elderly: not always what it seems.
3282PDF: 1017HTML: 1766Figure 1: 172Figure 1 revised: 175 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3135PDF: 1130HTML: 1476Untitled: 170Untitled: 162Untitled: 164 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5113PDF: 1311HTML: 2736Cover letter: 189 -
PREVALENCE OF SICKLE CELL TRAIT IN THE SOUTHERN SUBURBS OF BEIRUT, LEBANON
4083PDF: 1003HTML: 19152 -
PREVALENCE OF ß-THALASSEMIA MUTATIONS AMONG NORTHEASTERN IRANIAN POPULATION AND THEIR IMPACTS ON HEMATOLOGICAL INDICES AND APPLICATION OF PRENATAL DIAGNOSIS, A SEVEN-YEARS STUDY
2371PDF: 932HTML: 375Supplementary table 1: 214Some of the mutation detection samples: 209 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2158PDF: 1189HTML: 3701 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4207PDF: 1512HTML: 442







